-
DLBCL: Novel Drug Combo Boosts Survival in Older Adults
10 Apr 2025 11:43 GMT
TOPLINE:
Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) reduces the risk for disease progression, relapse, or death by 37% vs standard therapy in patients ≥ 70 years with diffuse large B-cell lymphoma (DLBCL …
-
How scientists developed a new way of examining rare cancer
14 Apr 2025 03:07 GMT
… test a wide range of drug combinations to find therapeutic vulnerabilities — specific … from testing a novel three-drug combination that not only shrank tumours …
-
Speedball Mike Bailey Reveals Origin Of His Nickname
13 Apr 2025 18:28 GMT
… ’s not Speedball after the drug combo, which is like a silly …
-
BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a Week
13 Apr 2025 15:14 GMT
… approval status of the drug combination to full FDA approval … in this indication, the drug combination led to median overall … At three years, the drug combination showed an overall survival rate … March approval of the drug combination in this indication.
There …
-
MAHA Commission Means Fear, Stigma, Health Threats for Two-Thirds of ADDitude Readers
11 Apr 2025 22:12 GMT
… tried to find the right drug combination for my daughter. Now we …
-
Ohtuvayre (ensifentrine) and cost
11 Apr 2025 13:17 GMT
… indicate that the drug or drug combination is safe, effective, or appropriate …
-
Azopt side effects and how to manage them
11 Apr 2025 12:21 GMT
… indicate that the drug or drug combination is safe, effective, or appropriate …
-
RED Talks event celebrates the future of innovation and discover at the U
11 Apr 2025 02:44 GMT
… risks associated with a particular drug combination for that patient.
Watch the …
-
Revolutionizing Healthcare: How AI and Automation Are Reshaping Precision Medicine
10 Apr 2025 21:58 GMT
… 8. AI also identifies effective drug combinations for chronic conditions, ensuring a …
-
Opinion: The National Cancer Institute’s Investigational New Drug program is imperative for public good
10 Apr 2025 18:14 GMT
… companies to conduct early phase drug combination studies.
Contrary to the impression …